Article Sidebar
Published:
Oct 3, 2018Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Taraxacum mongolicum extract exhibits antimicrobial activity against respiratory tract bacterial strains in vitro and in neonatal rats by enhancing systemic Th1 immunity
Abstract
Purpose: To study the antimicrobial activity of the Taraxacum mongolicum extract against respiratory infection-causing bacterial strains in vitro and in neonatal rats.
Methods: The in vitro antibacterial activity was assessed by micro-dilution method. Antioxidant activity was determined by ferric reducing antioxidant power (FRAP), nitro blue tetrazolium (NBT) and 2, 2- diphenyl-1-picrylhydrazyl (DPPH) assays. In vivo antimicrobial activity was evaluated in neonatal rat model. Interleukin (IL)-2 (IL-2) and gamma interferon (IFN-γ) were estimated using enzyme-linked immunosorbent assay (ELISA).
Results: The hydro-methanol extract of T. mongolicum contained high levels of phenolics and flavonoids, and exhibited strong antimicrobial activity against respiratory infection-causing bacterial species with MICs of 25 - 100 μg/ml, and MBCs of 55 - 215 μg/ml. The highest and lowest antimicrobial activities were observed against Streptococcus pneumonia and Haemophilus influenza, respectively. The extract at doses of 25 and 50 mg/kg exerted protective effects against Streptococcus pneumonia infected neonatal rats by boosting their Th1 immunity. It enhanced the production of interleukin (IL)-2, concomitant with decreased production of interferon (IFN)-γ in neonatal rats. The extract contained isoetin, hesperidin, naringenin, kaempferol, sinapinic and gallic acid.
Conclusion: These results suggest that the hydro-methanolic extract of Taraxacum mongolicum and its constituents can be potentially developed for use in the management of respiratory bacterial infections.
Keywords: Respiratory tract infection, Interleukin, Taraxacum mongolicum, Immunity, Neonatal rats
